Patients Coming Off Anti-Obesity Medications Gain Back Pounds Four Times Faster Than Those on Conventional Diets

A recent study indicates that people who discontinue new weight-loss injections like Mounjaro or Wegovy can put back on reduced body mass far faster than those who stop conventional lifestyle plans.

Findings released in a prominent medical journal points out that while overweight people frequently drop a large proportion of their body weight while on the medication, the mass returns at an estimated rate of 0.8 kg per month after stopping.

"Users buying such medications must be aware of the danger of quick rebound weight gain when the medication is stopped," cautioned researcher Dr. Susan Jebb.

That rate of regain suggests a reversion to starting weight within about 18 months.

Comparing Approaches

The research, which examined 37 of trials involving over 9,000 of participants, contrasted the results of GLP-1 agonists with older methods.

Scientists point out that people who shed pounds through diet and exercise generally have a slower creep back—approximately 100 grams monthly—post-intervention.

Explaining the Rapid Rebound

Doctors suggest the mechanism of the jabs is key to understanding the accelerated rebound.

The injections copy a body's own chemical called GLP-1, which helps regulate hunger.

"Long-term administration of the hormone levels far above than the body's typical production could lead to the system to produce less of its own natural GLP-1, and could reduce sensitivity to its actions," said Dr. Adam Collins, a nutrition researcher.

"Discontinuation of this medication results in appetite is no longer kept in check, making binge eating a significant risk."

An Ongoing Issue?

Medical guidelines advise the injections for people with weight-linked health risks, alongside recommended diet and exercise modifications.

Many experts argue that, considering the high risk of weight regain, the therapy is often long-term.

This perspective is reinforced by drug manufacturers, who say that the findings "highlight the long-term character of obesity," akin to managing diseases like diabetes.

User Experiences

Users who have come off the medication report a sudden return of cravings.

"It was like a trigger flipping and you're instantly ravenous," recalled one woman.

This difficulty is compounded if patients have not developed permanent dietary or behavioural modifications during treatment.

Growing Adoption

Recent estimates show that millions of adults in the UK have tried weight-loss jabs in the last 12 months, with interest remaining high.

• Adoption is higher among women compared to men.
• The middle-aged age group shows the highest level of interest.
• Many access the medications through private healthcare rather than public health services.

Ultimately, experts stress that while the jabs are powerful agents for weight loss, they are not a magic cure and maintained weight loss hinges on combined lifestyle changes.